Evidence map›Paper›PMID 38822187›Full record

ReviewWorld journal of microbiology & biotechnology2024

Role of bacterial multidrug efflux pumps during infection.

Pablo Laborda, Søren Molin, Helle Krogh Johansen, José Luis Martínez, Sara Hernando-Amado

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of microbiology & biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Phenotypic and Genomic Profiling ofAntibiotics (Basel, Switzerland) · 2026
    Article
  5. Review
  6. NosocomialInternational journal of molecular sciences · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pablo LabordaDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen, 9301, Denmark. palama@biosustain.dtu.dk.ORCID http://orcid.org/0000-0001-8281-7900
Søren MolinThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kgs. Lyngby, Denmark.ORCID http://orcid.org/0000-0002-7973-2639
Helle Krogh JohansenDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen, 9301, Denmark.ORCID http://orcid.org/0000-0003-0268-3717
José Luis MartínezCentro Nacional de Biotecnología, CSIC, Madrid, Spain.ORCID http://orcid.org/0000-0001-8813-7607
Sara Hernando-AmadoCentro Nacional de Biotecnología, CSIC, Madrid, Spain.ORCID http://orcid.org/0000-0001-5822-4996

Funding

Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación (MCIN/AEI) PID2020-113521RB-I00The Novo Nordisk Foundation (NNF) NNF19OC0056411
6 · The paper itself

Abstract

Multidrug efflux pumps are protein complexes located in the cell envelope that enable bacteria to expel, not only antibiotics, but also a wide array of molecules relevant for infection. Hence, they are important players in microbial pathogenesis. On the one hand, efflux pumps can extrude exogenous compounds, including host-produced antimicrobial molecules. Through this extrusion, pathogens can resist antimicrobial agents and evade host defenses. On the other hand, efflux pumps also have a role in the extrusion of endogenous compounds, such as bacterial intercommunication signaling molecules, virulence factors or metabolites. Therefore, efflux pumps are involved in the modulation of bacterial behavior and virulence, as well as in the maintenance of the bacterial homeostasis under different stresses found within the host. This review delves into the multifaceted roles that efflux pumps have, shedding light on their impact on bacterial virulence and their contribution to bacterial infection. These observations suggest that strategies targeting bacterial efflux pumps could both reinvigorate the efficacy of existing antibiotics and modulate the bacterial pathogenicity to the host. Thus, a comprehensive understanding of bacterial efflux pumps can be pivotal for the development of new effective strategies for the management of infectious diseases.

Indexed as

Anti-Bacterial AgentsBacteriaBacterial InfectionsBacterial ProteinsDrug Resistance, Multiple, BacterialMembrane Transport ProteinsVirulence FactorsAnimalsHumansVirulenceAnti-Bacterial AgentsBacterial ProteinsMembrane Transport ProteinsVirulence FactorsAntibiotic resistanceBacterial virulenceHost-microbe interactionsInfectionMultidrug efflux pumps

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.